Maobin Meng
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- DNA Repair Mechanisms 2
- Angiogenesis and VEGF in Cancer 2
- Oncology 9
- Cancer Cells and Metastasis 2
- PARP inhibition in cancer therapy 2
- Co-authors
- You Lü (9 shared papers)Yao‐Li Cui (5 shared papers)Zhiyong Yuan (20 shared papers)Ruiming Zhang (4 shared papers)Yong‐Song Guan (2 shared papers)Zhiqiang Wu (10 shared papers)Yan Chen (1 shared paper)Lei Deng (6 shared papers)
- Journals
- Radiotherapy and Oncology (6 papers)Cancer Science (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Oncotarget (1 paper)Radiation Oncology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Maobin Meng
46 papers receiving 817 citations
Peers
Comparison fields: 5 of 66
- Hepatology 148
- Cancer Research 110
- Radiation 66
- Oncology 177
- Pulmonary and Respiratory Medicine 168
Countries citing papers authored by Maobin Meng
This map shows the geographic impact of Maobin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maobin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maobin Meng more than expected).
Fields of papers citing papers by Maobin Meng
This network shows the impact of papers produced by Maobin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maobin Meng. The network helps show where Maobin Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Maobin Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 109 | |
| 2 | 2018 | 88 | |
| 3 | 2020 | 54 | |
| 4 | 2021 | 50 | |
| 5 | 2009 | 47 | |
| 6 | 2013 | 31 | |
| 7 | 2008 | 30 | |
| 8 | 2013 | 26 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 23 | |
| 11 | 2010 | 23 | |
| 12 | 2012 | 22 | |
| 13 | 2019 | 21 | |
| 14 | 2015 | 21 | |
| 15 | 2015 | 21 | |
| 16 | 2019 | 20 | |
| 17 | 2018 | 19 | |
| 18 | 2016 | 19 | |
| 19 | 2009 | 18 | |
| 20 | 2016 | 18 |
About Maobin Meng
Maobin Meng is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Surgery, having authored 46 papers that have together received 823 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Advanced Radiotherapy Techniques (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), DNA Repair Mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), PARP inhibition in cancer therapy (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Hepatology (148 citations), Cancer Research (110 citations), Radiation (66 citations), Oncology (177 citations) and Pulmonary and Respiratory Medicine (168 citations). Maobin Meng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include You Lü, Yao‐Li Cui, Zhiyong Yuan, Ruiming Zhang, Yong‐Song Guan, Zhiqiang Wu, Yan Chen, Lei Deng, Zeyun Mi and Xianming Mo. Their work appears in journals such as Radiotherapy and Oncology, Cancer Science, International Journal of Radiation Oncology*Biology*Physics, Oncotarget and Radiation Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.